Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7527)
All Articles published online
|
Publishing Process of This Article
|
Jul 14, 2017 (publication date) through Apr 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Paarnio K, Väyrynen S, Klintrup K, Ohtonen P, Mäkinen MJ, Mäkelä J, Karttunen TJ. Divergent expression of bacterial wall sensing Toll-like receptors 2 and 4 in colorectal cancer. World J Gastroenterol 2017; 23(26): 4831-4838 [PMID: 28765705 DOI: 10.3748/wjg.v23.i26.4831] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i26/4831.htm |
| Number | Citing Articles |
| 1 |
Shushan Yan, Guoyan Liu, Chengwen Jin, Zengfang Wang, Quanhong Duan, Jiang Xu, Donghua Xu. MicroRNA‐6869‐5p acts as a tumor suppressor via targeting TLR4/NF‐κB signaling pathway in colorectal cancer. Journal of Cellular Physiology 2018; 233(9): 6660 doi: 10.1002/jcp.26316
|
| 2 |
Reyhaneh Moradi‐Marjaneh, Seyed Mahdi Hassanian, Hamid Fiuji, Saman Soleimanpour, Gordon A. Ferns, Amir Avan, Majid Khazaei. Toll like receptor signaling pathway as a potential therapeutic target in colorectal cancer. Journal of Cellular Physiology 2018; 233(8): 5613 doi: 10.1002/jcp.26273
|
| 3 |
Guo-Min Liu, Tian-Cheng Lu, Mao-Lei Sun, Wen-Yuan Jia, Xuan Ji, Yun-Gang Luo. Ginsenoside Rd Inhibits Glioblastoma Cell Proliferation by Up-Regulating the Expression of miR-144-5p. Biological and Pharmaceutical Bulletin 2020; 43(10): 1534 doi: 10.1248/bpb.b20-00338
|
| 4 |
Tengfei Xiao, Mingzhong Sun, Yi Chang, Jingjing Kang, Chuanxiang Zhao, Rong Zhu, Hongmei Chen, Yetao Qiang. Butyrate impeded the conscription of MDSCs to reduce CAC formation by blocking the TLR2 signaling pathway. Journal of Functional Foods 2022; 99: 105344 doi: 10.1016/j.jff.2022.105344
|
| 5 |
Lucas de Freitas Pedrosa, João Paulo Fabi. Dietary fiber as a wide pillar of colorectal cancer prevention and adjuvant therapy. Critical Reviews in Food Science and Nutrition 2023; : 1 doi: 10.1080/10408398.2022.2164245
|
| 6 |
Ines Beilmann-Lehtonen, Camilla Böckelman, Harri Mustonen, Selja Koskensalo, Jaana Hagström, Caj Haglund. The prognostic role of tissue TLR2 and TLR4 in colorectal cancer. Virchows Archiv 2020; 477(5): 705 doi: 10.1007/s00428-020-02833-5
|
| 7 |
Fatma El Zahraa Mohamed, Rajiv Jalan, Shane Minogue, Fausto Andreola, Abeba Habtesion, Andrew Hall, Alison Winstanley, Steven Olde Damink, Massimo Malagó, Nathan Davies, Tu Vinh Luong, Amar Dhillon, Rajeshwar Mookerjee, Dipok Dhar, Rajai Munir Al-Jehani. Inhibition of TLR7 and TLR9 Reduces Human Cholangiocarcinoma Cell Proliferation and Tumor Development. Digestive Diseases and Sciences 2022; 67(5): 1806 doi: 10.1007/s10620-021-06973-9
|
| 8 |
Fanling Hong, Yujun Zhang, Wenjin Cheng, Xiuli Sun, Jianliu Wang. β-arrestin-2 up-regulates toll-like receptor 2 signaling and inhibits apoptosis in human endometrial cancer heterotransplants in nude mice. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-6254-4
|
| 9 |
Lili Li, Zhuoqian Zhou, Khangvu Mai, Ping Li, Zongqi Wang, Yaxi Wang, Yang Cao, Xuemeng Ma, Tingting Zhang, Daiyou Wang. Protein overexpression of toll‑like receptor 4 and myeloid differentiation factor 88 in oral squamous cell carcinoma and clinical significance. Oncology Letters 2021; 22(5) doi: 10.3892/ol.2021.13047
|
| 10 |
Nilesh Pandey, Alex Chauhan, Neeraj Jain. TLR4 Polymorphisms and Expression in Solid Cancers. Molecular Diagnosis & Therapy 2018; 22(6): 683 doi: 10.1007/s40291-018-0361-9
|
| 11 |
Karoliina Paarnio, Anne Tuomisto, Sara A. Väyrynen, Juha P. Väyrynen, Kai Klintrup, Pasi Ohtonen, Markus J. Mäkinen, Jyrki Mäkelä, Tuomo J. Karttunen. Serum TLR2 and TLR4 levels in colorectal cancer and their association with systemic inflammatory markers, tumor characteristics, and disease outcome. APMIS 2019; 127(8): 561 doi: 10.1111/apm.12971
|
| 12 |
Joon Koh, Zoya B. Kurago. Expanded Expression of Toll-Like Receptor 2 in Proliferative Verrucous Leukoplakia. Head and Neck Pathology 2019; 13(4): 635 doi: 10.1007/s12105-019-01028-y
|
| 13 |
You Dong Liu, Cheng Bo Ji, Shan Bao Li, Feng Yan, Qi Sheng Gu, Jesse J. Balic, Liang Yu, Ji Kun Li. Toll-like receptor 2 stimulation promotes colorectal cancer cell growth via PI3K/Akt and NF-κB signaling pathways. International Immunopharmacology 2018; 59: 375 doi: 10.1016/j.intimp.2018.04.033
|
| 14 |
Matheus Loureiro da Silva Cruz, Rafael Pereira dos Santos, Barbara Kunzler Souza, Mariane da Cunha Jaeger, Camila Alves da Silva, Lauro José Gregianin, Jiseh Fagundes Loss, Rebeca Ferreira Marques, Algemir Lunardi Brunetto, André Tesainer Brunetto, Rafael Roesler, Caroline Brunetto de Farias. Toll-like Receptors 2, 3, and 4 in Childhood Acute Lymphocytic Leukemia. Revista Brasileira de Cancerologia 2023; 69(3) doi: 10.32635/2176-9745.RBC.2023v69n3.3676
|
| 15 |
Ines Beilmann-Lehtonen, Jaana Hagström, Tuomas Kaprio, Ulf-Håkan Stenman, Karin Strigård, Richard Palmqvist, Ulf Gunnarsson, Camilla Böckelman, Caj Haglund. The Relationship between the Tissue Expression of TLR2, TLR4, TLR5, and TLR7 and Systemic Inflammatory Responses in Colorectal Cancer Patients. Oncology 2021; 99(12): 790 doi: 10.1159/000518397
|
| 16 |
Sven Jacob, Vindi Jurinovic, Christopher Lampert, Elise Pretzsch, Jörg Kumbrink, Jens Neumann, Ren Haoyu, Bernhard W. Renz, Thomas Kirchner, Markus O. Guba, Jens Werner, Martin K. Angele, Florian Bösch. The association of immunosurveillance and distant metastases in colorectal cancer. Journal of Cancer Research and Clinical Oncology 2021; 147(11): 3333 doi: 10.1007/s00432-021-03753-w
|
| 17 |
Nourhan Hossam, Marwa Matboli, Hanan H. Shehata, Marwa M. Aboelhussein, Mohamed Kamel Hassan, Sanaa Eissa. Toll-like receptor immune modulatory role in personalized management of colorectal cancer, review of literature. Expert Review of Precision Medicine and Drug Development 2020; 5(6): 455 doi: 10.1080/23808993.2020.1816136
|
| 18 |
Antonino Di Lorenzo, Elisabetta Bolli, Lidia Tarone, Federica Cavallo, Laura Conti. Toll-Like Receptor 2 at the Crossroad between Cancer Cells, the Immune System, and the Microbiota. International Journal of Molecular Sciences 2020; 21(24): 9418 doi: 10.3390/ijms21249418
|
| 19 |
Wei Ping, Senyuan Hong, Yang Xun, Cong Li, Mujeeb Zafar Banday. Comprehensive Bioinformatics Analysis of Toll-Like Receptors (TLRs) in Pan-Cancer. BioMed Research International 2022; 2022: 1 doi: 10.1155/2022/4436646
|
| 20 |
Lifang Zhao, Zhaoying Fu. Roles of Host Immunity in Viral Myocarditis and Dilated Cardiomyopathy. Journal of Immunology Research 2018; 2018: 1 doi: 10.1155/2018/5301548
|
| 21 |
Tengfei Xiao, Shuiyun Wu, Cheng Yan, Chuanxiang Zhao, Huimin Jin, Nannan Yan, Jie Xu, Yi Wu, Ci Li, Qixiang Shao, Sheng Xia. Butyrate upregulates the TLR4 expression and the phosphorylation of MAPKs and NK‑κB in colon cancer cell in�vitro. Oncology Letters 2018; doi: 10.3892/ol.2018.9201
|